Active Immunization of Metastatic Melanoma Patients with Interleukin-4 Transduced, Allogeneic Melanoma Cells. A Phase I–II Study. University of Turin, Italy
- 1 August 1994
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 5 (8) , 1059-1064
- https://doi.org/10.1089/hum.1994.5.8-1059
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.The Journal of Experimental Medicine, 1993